Citigroup’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.5M Sell
67,487
-16,197
-19% -$387K ﹤0.01% 2852
2025
Q4
$2.24M Sell
83,684
-1,490,386
-95% -$35.6M ﹤0.01% 2583
2025
Q3
$33.6M Sell
1,574,070
-92,770
-6% -$2.19M 0.02% 799
2025
Q2
$36M Sell
1,666,840
-185,543
-10% -$3.45M 0.02% 701
2025
Q1
$30.8M Buy
1,852,383
+184,615
+11% +$3.35M 0.02% 769
2024
Q4
$30.6M Buy
1,667,768
+1,547,641
+1,288% +$25M 0.03% 735
2024
Q3
$1.85M Buy
120,127
+53,287
+80% +$889K ﹤0.01% 2742
2024
Q2
$1.09M Sell
66,840
-287,063
-81% -$4.63M ﹤0.01% 2855
2024
Q1
$6.54M Buy
353,903
+131,185
+59% +$3.25M 0.01% 1530
2023
Q4
$6.97M Buy
222,718
+75,854
+52% +$1.81M 0.01% 1393
2023
Q3
$3.06M Buy
146,864
+2,786
+2% +$75.7K ﹤0.01% 1713
2023
Q2
$3.45M Sell
144,078
-134,450
-48% -$2.99M ﹤0.01% 1751
2023
Q1
$5.24M Buy
278,528
+23,690
+9% +$451K 0.01% 1486
2022
Q4
$4.06M Sell
254,838
-123,892
-33% -$1.94M 0.01% 1573
2022
Q3
$6.2M Buy
378,730
+114,242
+43% +$1.85M 0.01% 1425
2022
Q2
$3.73M Buy
264,488
+216,941
+456% +$4.05M 0.01% 1705
2022
Q1
$1.15M Sell
47,547
-173,146
-78% -$4.19M ﹤0.01% 2831
2021
Q4
$5.15M Sell
220,693
-5,884
-3% -$118K ﹤0.01% 1809
2021
Q3
$3.76M Buy
226,577
+53,123
+31% +$1.02M ﹤0.01% 2014
2021
Q2
$4.23M Sell
173,454
-21,313
-11% -$481K ﹤0.01% 2045
2021
Q1
$5.02M Buy
194,767
+108,189
+125% +$4.76M ﹤0.01% 1784
2020
Q4
$4.63M Buy
86,578
+29,603
+52% +$1.47M 0.01% 2139
2020
Q3
$2.35M Sell
56,975
-200,274
-78% -$8.65M ﹤0.01% 2506
2020
Q2
$12.5M Buy
257,249
+141,645
+123% +$6.8M 0.02% 1148
2020
Q1
$4.88M Buy
115,604
+19,008
+20% +$783K 0.01% 1694
2019
Q4
$4.13M Sell
96,596
-15,000
-13% -$653K 0.01% 2197
2019
Q3
$4.02M Sell
111,596
-140,195
-56% -$4.25M 0.01% 2142
2019
Q2
$6.73M Buy
251,791
+188,877
+300% +$4.82M 0.01% 1722
2019
Q1
$1.69M Sell
62,914
-667,490
-91% -$15.6M ﹤0.01% 2840
2018
Q4
$11.8M Buy
730,404
+446,926
+158% +$8.68M 0.02% 1148
2018
Q3
$5.89M Buy
283,478
+204,749
+260% +$3.22M 0.01% 1707
2018
Q2
$1.2M Buy
78,729
+34,220
+77% +$610K ﹤0.01% 3157
2018
Q1
$1M Sell
44,509
-28,522
-39% -$790K ﹤0.01% 3233
2017
Q4
$2.2M Buy
73,031
+26,626
+57% +$851K ﹤0.01% 2580
2017
Q3
$1.75M Sell
46,405
-59,620
-56% -$1.94M ﹤0.01% 2798
2017
Q2
$2.96M Buy
106,025
+1,562
+1% +$46.5K 0.01% 2177
2017
Q1
$3.59M Sell
104,463
-295,703
-74% -$10.4M 0.01% 1931
2016
Q4
$11.5M Buy
400,166
+328,688
+460% +$8.7M 0.02% 1091
2016
Q3
$2.27M Buy
71,478
+5,487
+8% +$186K 0.01% 2398
2016
Q2
$2.14M Sell
65,991
-55,259
-46% -$1.85M ﹤0.01% 2288
2016
Q1
$3.39M Buy
121,250
+75,051
+162% +$1.64M 0.01% 1921
2015
Q4
$1.65M Sell
46,199
-453
-1% -$16K ﹤0.01% 2636
2015
Q3
$1.54M Buy
46,652
+6,203
+15% +$258K ﹤0.01% 2687
2015
Q2
$1.69M Sell
40,449
-37,167
-48% -$1.44M ﹤0.01% 2696
2015
Q1
$2.53M Buy
77,616
+55,345
+249% +$1.9M ﹤0.01% 2279
2014
Q4
$707K Buy
22,271
+7,745
+53% +$220K ﹤0.01% 3517
2014
Q3
$360K Sell
14,526
-5,548
-28% -$130K ﹤0.01% 3782
2014
Q2
$453K Sell
20,074
-1,382
-6% -$28.9K ﹤0.01% 3528
2014
Q1
$522K Sell
21,456
-45,668
-68% -$1.16M ﹤0.01% 3423
2013
Q4
$1.68M Buy
67,124
+35,347
+111% +$834K ﹤0.01% 2737
2013
Q3
$873K Sell
31,777
-2,108
-6% -$44.1K ﹤0.01% 2999
2013
Q2
$615K Buy
+33,885
New +$467K ﹤0.01% 3298

Other funds holding ACAD